| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/20/2013 | CN102935099A Extractive capable of reducing insulin resistance as well as preparation method and application thereof |
| 02/20/2013 | CN102935083A Application of phenylethanoid glycoside monomer compounds |
| 02/20/2013 | CN102935077A Bionic lovastatin nano-structured lipid carrier and preparation method thereof |
| 02/20/2013 | CN102175682B Bioactivity detection method and application of recombined humanized neuroglobin |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/20/2013 | CN102028711B Enzymatically synthesized triglyceride type fish oil soft capsules and preparation method thereof |
| 02/20/2013 | CN102008710B Lisinopril-containing compound preparation for treating hypertension |
| 02/20/2013 | CN102008708B Ramipril-contained compound preparation for treating hypertension |
| 02/20/2013 | CN101849675B Dietary supplements containing natural ingredients |
| 02/20/2013 | CN101838213B Method for preparing laminine and pharmaceutically acceptable salts thereof |
| 02/20/2013 | CN101703488B Two-layer osmotic pump controlled release tablet with lubricating layer structure and preparation method thereof |
| 02/20/2013 | CN101701219B cDNA for encoding rabbit hepatocyte growth factor and expression vector and application thereof |
| 02/20/2013 | CN101700265B Application of notoginseng and extract thereof in preparing medicament for curing and/or preventing diabetic microangiopathies |
| 02/19/2013 | USRE44022 Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators |
| 02/19/2013 | US8378118 Pyrazole-based thyroid receptor compounds |
| 02/19/2013 | US8378108 Apoptosis signal-regulating kinase inhibitors |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377916 Steroids as agonists for FXR |
| 02/19/2013 | US8377913 Vitamin D receptor activators and methods of making |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | US8377878 Therapies for chronic renal failure |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377692 Process for the manufacturing of human mononuclear phagocytic leukocytes |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | CA2558314C Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure |
| 02/19/2013 | CA2538478C A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/19/2013 | CA2372947C Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 02/14/2013 | WO2013022447A1 Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
| 02/14/2013 | WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 02/14/2013 | WO2013021302A1 Anti-oxidant herbal composition |
| 02/14/2013 | WO2013020995A1 New antibodies against phosphorylcholine |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020371A1 Pim kinase inhibitor, preparation method and use thereof in drug preparation |
| 02/14/2013 | WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
| 02/14/2013 | WO2013020184A1 Flavonoid compounds, and methods of use thereof |
| 02/14/2013 | WO2012148148A9 Novel zinc azide complex and a process for preparing tetrazole derivatives using the same |
| 02/14/2013 | WO2012128502A3 Composition for promoting vasculogenesis comprising pauf |
| 02/14/2013 | WO2012116349A3 Novel cocrystals of ezetimibe |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041418 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide |
| 02/14/2013 | US20130041348 Catheter-Based Delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts |
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130041040 Solid pharmaceutical composition for buccal administration of agomelatine |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041005 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| 02/14/2013 | US20130041002 Denibulin di-hydrochloride |
| 02/14/2013 | US20130041001 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| 02/14/2013 | US20130040997 Novel pyridine carboxylic acid based compound used as a p2x1 and p2x3 receptor antagonist, a production method for the same and a composition comprising the same |
| 02/14/2013 | US20130040996 Composition for treating atherosclerosis and a preparation method thereof |
| 02/14/2013 | US20130040994 Methods of Treatment Using Allosteric Processing Inhibitors for Matrix Metalloproteinases |
| 02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
| 02/14/2013 | US20130040988 3-amino-pyridine derivatives for the treatment of metabolic disorders |
| 02/14/2013 | US20130040982 Oral sustained release formulation of huperzine a |
| 02/14/2013 | US20130040981 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives |
| 02/14/2013 | US20130040950 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/14/2013 | US20130040941 Benzodiazepine compound and pharmaceutical composition |
| 02/14/2013 | US20130040940 Mercaptoamidine derivatives and methods of use |
| 02/14/2013 | US20130040937 Inhibitors for treating and preventing heart failure in felines |
| 02/14/2013 | US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics |
| 02/14/2013 | US20130040927 Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| 02/14/2013 | US20130040919 C-nitroso-derived nitroxyl donors |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040913 Omega 3 fatty acidfor use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (cvd) who are deficient in blood epa and dha levels |
| 02/14/2013 | US20130040912 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
| 02/14/2013 | US20130040904 Method of treatment using alpha-1-adrenergic agonist compounds |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040898 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| 02/14/2013 | US20130040896 Methods and compositions for modulating angiogenesis and pericyte composition |
| 02/14/2013 | US20130040891 Chemically modified water-soluble elastin, mixed gel of chemically modified water-soluble elastin and collagen, and process for producing same |
| 02/14/2013 | US20130040881 Ltbp2 as a biomarker for renal dysfunction |
| 02/14/2013 | US20130040879 Methods For Treating Congestive Heart Failure |
| 02/14/2013 | US20130040006 Extracts of Eleutherococcus SPP., Preparation Method Thereof and Use of the Same |
| 02/14/2013 | US20130040005 Antihypertensive agents |
| 02/14/2013 | US20130040002 Anti-oxidant herbal composition |
| 02/14/2013 | US20130039993 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures |
| 02/14/2013 | US20130039984 Manufacture process for the preparation of an iron containing phosphate adsorbent |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039975 Liposomes Containing Prostaglandin E1 (PGE1), Formulations Containing Them and Their Use |
| 02/14/2013 | US20130039971 Compositions and methods for inhibition of vegf |
| 02/14/2013 | US20130039970 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 02/14/2013 | US20130039919 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039902 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/14/2013 | US20130039901 Treatment of Pompe's Disease |
| 02/14/2013 | US20130039897 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039853 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | US20130039847 Liposomes for pulmonary administration |
| 02/14/2013 | CA2851575A1 Methods and compositions for inhibiting delayed graft function |
| 02/14/2013 | CA2844855A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |